1163442006: Voglibose (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Glycosidase inhibitor\Substance with alpha-glucosidase inhibitor mechanism of action (substance)\Voglibose

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Carbohydrate derivative\Sugar alcohol\Voglibose

\Substance with alcohol structure (substance)\Sugar alcohol\Voglibose

\Carbohydrate\Sugar alcohol\Voglibose

\Biological substance\Nutrients\Carbohydrate\Sugar alcohol\Voglibose

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4596875014 Voglibose en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4596876010 Voglibose (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Voglibose	Is a	Sugar alcohol	true	Inferred relationship	Some
Voglibose	Is a	Substance with alpha-glucosidase inhibitor mechanism of action (substance)	true	Inferred relationship	Some
Voglibose	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-glucosidase inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Voglibose-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Voglibose	Inferred relationship	Some	1
Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Voglibose	Inferred relationship	Some	1
Voglibose only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Product containing voglibose in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Voglibose only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Voglibose 300 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Voglibose	Inferred relationship	Some	1
Voglibose 300 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Voglibose	Inferred relationship	Some	1
Metformin- and voglibose-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Product containing only metformin and voglibose (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Product containing metformin and voglibose in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Metformin and voglibose only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Voglibose	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and voglibose 200 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Voglibose	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and voglibose 200 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Voglibose	Inferred relationship	Some	2

Reference Sets